 MONMOUTH JUNCTION, N.J., March 29, 2021 PRNewswire -- CytoSorbents Corporation NASDAQ: CTSO, a critical care immunotherapy leader commercializing its CytoSorb blood purification technology to treat deadly inflammation in critically-ill and cardiac surgery patients around the world, announces the lease of its new global headquarters in Princeton, NJ. 